 Patricia Huguelet
Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gynecology | 11 | 2022 | 178 | 3.540 |
Why?
| | Intrauterine Devices, Medicated | 4 | 2023 | 27 | 2.120 |
Why?
| | Contraceptive Agents, Female | 3 | 2023 | 80 | 1.830 |
Why?
| | Menorrhagia | 3 | 2023 | 22 | 1.570 |
Why?
| | Ehlers-Danlos Syndrome | 2 | 2023 | 16 | 1.470 |
Why?
| | Adolescent Medicine | 5 | 2020 | 26 | 1.450 |
Why?
| | Vulvar Diseases | 2 | 2022 | 9 | 1.420 |
Why?
| | Internship and Residency | 7 | 2022 | 1257 | 1.130 |
Why?
| | Pediatrics | 6 | 2020 | 1114 | 1.080 |
Why?
| | Levonorgestrel | 3 | 2023 | 35 | 0.860 |
Why?
| | Curriculum | 8 | 2022 | 1059 | 0.830 |
Why?
| | Leuprolide | 1 | 2022 | 21 | 0.750 |
Why?
| | Stomatitis, Aphthous | 1 | 2022 | 9 | 0.750 |
Why?
| | Obstetrics | 2 | 2022 | 175 | 0.740 |
Why?
| | Transgender Persons | 2 | 2022 | 191 | 0.730 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 180 | 0.670 |
Why?
| | Clinical Competence | 2 | 2020 | 1244 | 0.670 |
Why?
| | Virus Diseases | 1 | 2022 | 216 | 0.620 |
Why?
| | Endocrinology | 1 | 2020 | 77 | 0.600 |
Why?
| | Vagina | 3 | 2024 | 201 | 0.590 |
Why?
| | Adolescent | 21 | 2026 | 22428 | 0.560 |
Why?
| | Genitalia, Female | 1 | 2018 | 42 | 0.560 |
Why?
| | Simulation Training | 1 | 2020 | 134 | 0.550 |
Why?
| | Adnexa Uteri | 1 | 2017 | 5 | 0.530 |
Why?
| | Torsion Abnormality | 1 | 2017 | 20 | 0.520 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 354 | 0.490 |
Why?
| | Anal Canal | 1 | 2016 | 102 | 0.470 |
Why?
| | Uterine Hemorrhage | 1 | 2015 | 41 | 0.460 |
Why?
| | Pregnancy | 9 | 2026 | 7190 | 0.450 |
Why?
| | Female | 32 | 2026 | 78271 | 0.440 |
Why?
| | Transplant Recipients | 1 | 2016 | 180 | 0.440 |
Why?
| | Amenorrhea | 1 | 2014 | 31 | 0.430 |
Why?
| | Emergency Treatment | 1 | 2015 | 124 | 0.430 |
Why?
| | Endometriosis | 1 | 2014 | 57 | 0.410 |
Why?
| | Hysterosalpingography | 1 | 2013 | 8 | 0.400 |
Why?
| | Sterilization, Tubal | 1 | 2013 | 17 | 0.400 |
Why?
| | Pregnancy, Ectopic | 1 | 2013 | 53 | 0.390 |
Why?
| | Menstrual Cycle | 2 | 2025 | 140 | 0.380 |
Why?
| | Young Adult | 10 | 2025 | 14105 | 0.360 |
Why?
| | Students, Medical | 1 | 2016 | 375 | 0.340 |
Why?
| | Child | 14 | 2025 | 22633 | 0.340 |
Why?
| | Humans | 35 | 2026 | 144759 | 0.320 |
Why?
| | 46, XX Disorders of Sex Development | 2 | 2022 | 7 | 0.310 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1414 | 0.260 |
Why?
| | Informed Consent By Minors | 1 | 2026 | 2 | 0.250 |
Why?
| | Mental Competency | 1 | 2026 | 26 | 0.240 |
Why?
| | Congenital Abnormalities | 3 | 2022 | 104 | 0.240 |
Why?
| | Treatment Refusal | 1 | 2026 | 98 | 0.230 |
Why?
| | Confidentiality | 1 | 2026 | 79 | 0.230 |
Why?
| | Educational Measurement | 2 | 2020 | 326 | 0.230 |
Why?
| | Retrospective Studies | 6 | 2022 | 17066 | 0.220 |
Why?
| | Abdominal Pain | 2 | 2017 | 146 | 0.220 |
Why?
| | Informed Consent | 1 | 2026 | 198 | 0.210 |
Why?
| | Societies, Medical | 3 | 2018 | 887 | 0.210 |
Why?
| | Pelvis | 1 | 2025 | 124 | 0.210 |
Why?
| | Hemorrhagic Disorders | 1 | 2023 | 10 | 0.200 |
Why?
| | Hymen | 2 | 2022 | 5 | 0.200 |
Why?
| | Ulcer | 1 | 2022 | 37 | 0.180 |
Why?
| | Mobile Applications | 1 | 2025 | 196 | 0.180 |
Why?
| | Particulate Matter | 1 | 2025 | 347 | 0.180 |
Why?
| | Mullerian Ducts | 2 | 2022 | 17 | 0.170 |
Why?
| | Blood Coagulation Disorders | 1 | 2023 | 189 | 0.170 |
Why?
| | Imaging, Three-Dimensional | 1 | 2025 | 583 | 0.170 |
Why?
| | Hemophilia A | 1 | 2023 | 147 | 0.170 |
Why?
| | Emergencies | 1 | 2022 | 175 | 0.170 |
Why?
| | Diagnosis, Differential | 2 | 2016 | 1489 | 0.170 |
Why?
| | Laparoscopy | 2 | 2017 | 475 | 0.170 |
Why?
| | Air Pollution | 1 | 2025 | 327 | 0.170 |
Why?
| | Adult | 9 | 2025 | 40449 | 0.170 |
Why?
| | Environmental Exposure | 1 | 2025 | 588 | 0.160 |
Why?
| | Air Pollutants | 1 | 2025 | 438 | 0.160 |
Why?
| | Stents | 1 | 2024 | 556 | 0.160 |
Why?
| | Single-Blind Method | 1 | 2020 | 312 | 0.150 |
Why?
| | Prospective Studies | 4 | 2025 | 7990 | 0.150 |
Why?
| | Reference Values | 2 | 2018 | 797 | 0.150 |
Why?
| | Coitus | 1 | 2019 | 23 | 0.150 |
Why?
| | Biological Variation, Population | 1 | 2018 | 20 | 0.140 |
Why?
| | Urethra | 1 | 2019 | 57 | 0.140 |
Why?
| | Decision Making | 1 | 2026 | 975 | 0.140 |
Why?
| | Testosterone | 1 | 2022 | 419 | 0.140 |
Why?
| | Gynecologic Surgical Procedures | 1 | 2018 | 64 | 0.140 |
Why?
| | Parovarian Cyst | 1 | 2017 | 2 | 0.130 |
Why?
| | Salpingectomy | 1 | 2017 | 15 | 0.130 |
Why?
| | Metformin | 1 | 2021 | 318 | 0.130 |
Why?
| | Adenocarcinoma, Papillary | 1 | 2016 | 11 | 0.130 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 6048 | 0.120 |
Why?
| | Gallbladder Neoplasms | 1 | 2016 | 20 | 0.120 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 357 | 0.120 |
Why?
| | Norethindrone | 1 | 2015 | 2 | 0.120 |
Why?
| | Clitoris | 1 | 2016 | 9 | 0.120 |
Why?
| | Menstruation Disturbances | 1 | 2015 | 13 | 0.120 |
Why?
| | Comorbidity | 1 | 2021 | 1658 | 0.120 |
Why?
| | Contraceptives, Oral, Combined | 1 | 2015 | 18 | 0.120 |
Why?
| | Intestine, Small | 1 | 2016 | 166 | 0.110 |
Why?
| | North America | 1 | 2016 | 310 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 1 | 2024 | 1356 | 0.110 |
Why?
| | Hematometra | 1 | 2014 | 5 | 0.110 |
Why?
| | Physicians | 3 | 2018 | 939 | 0.110 |
Why?
| | Education, Medical, Graduate | 2 | 2017 | 557 | 0.110 |
Why?
| | Vaccination | 1 | 2022 | 1423 | 0.100 |
Why?
| | United States | 4 | 2025 | 15966 | 0.100 |
Why?
| | Pregnancy, Unplanned | 1 | 2013 | 48 | 0.100 |
Why?
| | Pelvic Pain | 1 | 2013 | 43 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3409 | 0.090 |
Why?
| | Pandemics | 1 | 2021 | 1694 | 0.090 |
Why?
| | Skin | 1 | 2016 | 755 | 0.090 |
Why?
| | Kidney Transplantation | 1 | 2016 | 704 | 0.080 |
Why?
| | Heart Transplantation | 1 | 2016 | 736 | 0.080 |
Why?
| | Liver Transplantation | 1 | 2016 | 823 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1560 | 0.070 |
Why?
| | Goals | 2 | 2023 | 183 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2023 | 11679 | 0.070 |
Why?
| | Colorado | 1 | 2017 | 4564 | 0.060 |
Why?
| | Obesity | 1 | 2020 | 3077 | 0.060 |
Why?
| | Personal Autonomy | 1 | 2026 | 57 | 0.060 |
Why?
| | Infant | 2 | 2016 | 10034 | 0.060 |
Why?
| | Male | 4 | 2022 | 72315 | 0.060 |
Why?
| | Brazil | 1 | 2025 | 180 | 0.050 |
Why?
| | Child, Preschool | 2 | 2017 | 11787 | 0.050 |
Why?
| | Mexico | 1 | 2025 | 233 | 0.050 |
Why?
| | Vaginal Diseases | 1 | 2024 | 18 | 0.050 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 5868 | 0.050 |
Why?
| | Constriction, Pathologic | 1 | 2024 | 248 | 0.050 |
Why?
| | Dilatation | 1 | 2022 | 72 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3863 | 0.040 |
Why?
| | Focus Groups | 1 | 2024 | 573 | 0.040 |
Why?
| | Hirsutism | 1 | 2021 | 11 | 0.040 |
Why?
| | Ultrasonography | 1 | 2025 | 770 | 0.040 |
Why?
| | Alopecia | 1 | 2021 | 37 | 0.040 |
Why?
| | Hormones | 1 | 2021 | 134 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2023 | 222 | 0.040 |
Why?
| | Neuropeptides | 1 | 2001 | 77 | 0.040 |
Why?
| | Brain Chemistry | 1 | 2001 | 116 | 0.040 |
Why?
| | Self Report | 1 | 2025 | 872 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2023 | 281 | 0.040 |
Why?
| | Membrane Transport Proteins | 1 | 2001 | 154 | 0.040 |
Why?
| | Dilatation, Pathologic | 1 | 2019 | 62 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2019 | 95 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 2001 | 496 | 0.030 |
Why?
| | Bipolar Disorder | 1 | 2001 | 280 | 0.030 |
Why?
| | Schizophrenia | 1 | 2001 | 446 | 0.030 |
Why?
| | Vulva | 1 | 2016 | 23 | 0.030 |
Why?
| | Caregivers | 1 | 2023 | 1049 | 0.030 |
Why?
| | Learning | 1 | 2017 | 452 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2024 | 2919 | 0.020 |
Why?
| | Vesicular Biogenic Amine Transport Proteins | 1 | 2001 | 1 | 0.010 |
Why?
| | Vesicular Monoamine Transport Proteins | 1 | 2001 | 9 | 0.010 |
Why?
| | Tomography, Emission-Computed | 1 | 2001 | 71 | 0.010 |
Why?
| | Schizophrenic Psychology | 1 | 2001 | 97 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2001 | 541 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2001 | 780 | 0.010 |
Why?
|
|
Huguelet's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|